Technical Analysis for ARCT - Arcturus Therapeutics Ltd.

Grade Last Price % Change Price Change
F 28.86 11.90% 3.07
ARCT closed up 11.9 percent on Friday, May 14, 2021, on 81 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical ARCT trend table...

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 11.90%
Spinning Top Other 11.90%
Lower Bollinger Band Walk Weakness 11.90%
New 52 Week Low Weakness 11.90%
Wide Bands Range Expansion 11.90%
Down 3 Days in a Row Weakness 11.90%
Older End-of-Day Signals for ARCT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Arcturus Therapeutics Ltd. Description

Alcobra Ltd is a development-stage biopharmaceutical company. The Company is focused on development and commercialization of its lead product candidates, including MDX and ADAIR. MDX is a oral drug, for the treatment of ADHD and other cognitive disorders, including Fragile X. MDX is a combined rapid onset ER formulation of the chemical pyridoxine pyroglutamate, which is more commonly known as metadoxine. MDX consists of a single bi-layer oral tablet, which includes both a rapid onset release metadoxine formulation and a slow release metadoxine formulation together providing the desired dual release profile. The new extended-release formulation prolongs the human plasma levels of metadoxine for up to 12 hours, which results in enhanced efficacy benefits. ADAIR is an oral, semi-solid, liquid-filled, hard gelatin capsule of an abuse-deterrent IR formulation of dextroamphetamine sulfate, which is manufactured as 10 mg capsules.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Pharmaceutical Industry Drugs Health Sciences Pharmacology Euphoriants Dosage Forms Amphetamine Cognitive Disorders Glutamate Adhd Tablet Mdx Taar1 Agonists

Is ARCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 129.71
52 Week Low 24.87
Average Volume 613,682
200-Day Moving Average 55.95
50-Day Moving Average 39.45
20-Day Moving Average 33.83
10-Day Moving Average 30.05
Average True Range 2.75
ADX 37.7
+DI 12.89
-DI 37.49
Chandelier Exit (Long, 3 ATRs ) 33.47
Chandelier Exit (Short, 3 ATRs ) 33.13
Upper Bollinger Band 42.68
Lower Bollinger Band 24.98
Percent B (%b) 0.22
BandWidth 52.30
MACD Line -3.84
MACD Signal Line -3.38
MACD Histogram -0.4549
Fundamentals Value
Market Cap 706.87 Million
Num Shares 24.5 Million
EPS -1.26
Price-to-Earnings (P/E) Ratio -22.89
Price-to-Sales 140.45
Price-to-Book 7.63
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 33.59
Resistance 3 (R3) 33.09 31.02 32.80
Resistance 2 (R2) 31.02 29.82 31.27 32.53
Resistance 1 (R1) 29.94 29.07 30.48 30.44 32.27
Pivot Point 27.87 27.87 28.14 28.12 27.87
Support 1 (S1) 26.79 26.67 27.33 27.29 25.45
Support 2 (S2) 24.72 25.92 24.97 25.19
Support 3 (S3) 23.64 24.72 24.92
Support 4 (S4) 24.14